Candel Therapeutics grants options on 107,600 shares to four new employees
CADL•Candel Therapeutics granted four new employees options to purchase 107,600 shares at an exercise price of $8.33 per share.
1. Option grants
The options were granted on Oct. 31, 2026, under the 2025 Inducement Plan. Twenty-five percent of the underlying shares vest on each employee’s first anniversary, with the remaining 75% vesting in 36 equal monthly installments, subject to continued service.
